Robert J. Rafka
10Patents
4h-index
15Co-inventors
53Inventor score
Filing activity: Sep 23, 1986 → May 6, 2004
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4808626A | Use of 2,5-anhydro-D-mannitol as a food intake modifier | Human Necessities | 14 | Expired |
| US6007848A | Use of 1,4-anhydroglucitol/galactitol in low calorie food products, and a method of preparing 1,4-anhydro-dl-galactitol | Human Necessities | 14 | Expired |
| US6100240A | Macrolide derivatives | Emerging Cross-Sectional Technologies | 7 | Expired |
| US6329345A | 13-membered azalides and their use as antibiotic agents | Chemistry; Metallurgy | 4 | Expired |
| US4871776A | 2,5-anhydro-1,6-dihalo-1,6-dideoxy-D-mannitol | Human Necessities | 3 | Expired |
| US6465437B1 | Diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-9A- homoerythromycin derivative and its pharmaceutical composition | Emerging Cross-Sectional Technologies | 2 | Expired |
| US6583274B1 | Crystalline forms of macrolide antibiotic | Chemistry; Metallurgy | 1 | Expired |
| US6861412B2 | Diphosphate salt of A 4″-substituted-9-deoxo-9A-AZA-9A-homoerythromycin derivative and its pharmaceutical composition | Emerging Cross-Sectional Technologies | 1 | Expired |
| US7297682B2 | Diphosphate salt of a 4″—substituted-9-deoxo-9 A—AZA—homoerythromycin derivatives and its pharmaceutical composition | Emerging Cross-Sectional Technologies | 0 | Expired |
| US4954531A | Use of 2,5-anhydro-d-mannitol as a food intake modifier | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.